Status:

UNKNOWN

Central Effects of Botulinum Toxin: Neurophysiological Study in Stroke Patients With Spastic Lower Limb

Lead Sponsor:

Assistance Publique Hopitaux De Marseille

Conditions:

Hemiplegic Patients Post-AVC

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Spasticity is a motor disorder characterized by a velocity-dependent increase in tonic stretch reflex with exaggerated tendon jerk (Lance 1980). Patients with brain lesion often display spasticity due...

Eligibility Criteria

Inclusion

  • More than 18-years-old Patient
  • Patient presenting a hemiplegia séquellaire of an AVC above - tentoriel dating more than 12 months
  • Patient presenting a spasticité of the muscles of the leg
  • Patient for him(it) ( a ) which an indication of treatment(processing) by botulinal toxin is carried(worn)
  • Patient not having received from treatment(processing) by botulinal toxin at the level of the lower limb for six months
  • Patient not having benefited from alcoholization or surgical gesture(movement) at the level of the lower limb for twelve months
  • Spasticité focused the muscles of leg: soleus, gastrocnémiens, with score of Ashworth \> or = 2 on the concerned muscles and/or the presence of a clonus on the soleus or gastrocnémiens,

Exclusion

  • Patient for him(it) ( a ) which the upright posture and/or the walking(step) are impossible
  • Patient presenting a contraindication to the use of the botulinal toxin
  • Patient presenting a contraindication to the use of the intramuscular way
  • Patient susceptible not to participate in the totality of the study
  • Woman pregnant or susceptible to be pregnant during the year
  • Patient who can not give himself(itself) his consent (held(detained), major under guardianship)
  • Patient incapable to understand(include) the nature and the purposes of the study, or presenting difficulties of understanding which can compromise the good progress of the study

Key Trial Info

Start Date :

April 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2015

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT01829763

Start Date

April 1 2013

End Date

November 1 2015

Last Update

July 24 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Assistance Publique Hopitaux de Marseille

Marseille, France, 13354